CLINICAL_TRIALS
ClinicalTrials.gov record update
CHEMO-T: Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (CHOP) Versus Gemcitabine, Cisplatin and Methyl Prednisolone (GEM-P) in the First Line Treatment Of T-cell Lymphoma,a Multicentre Randomised Phase II Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01719835
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:59.224394+00:00
- Published At
- 2018-03-15T00:00:00+00:00
- Record Updated At
- 2018-03-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Peripheral T-cell Lymphoma NOS", "Anaplastic Large Cell Lymphoma, ALK-Negative", "Angioimmunoblastic T-cell Lymphoma", "Hepatosplenic Gamma/ Delta T-cell Lymphoma", "Enteropathy-Associated T-Cell Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-03-15"- protocolSection.identificationModule.nctId
"NCT01719835"- protocolSection.identificationModule.officialTitle
"CHEMO-T: Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (CHOP) Versus Gemcitabine, Cisplatin and Methyl Prednisolone (GEM-P) in the First Line Treatment Of T-cell Lymphoma,a Multicentre Randomised Phase II Study"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.